Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation.

Bruno L, Cortese M, Monda G, Gentile M, Calò S, Schiavetti F, Zedda L, Cattaneo E, Piccioli D, Schaefer M, Notomista E, Maione D, Carfì A, Merola M, Uematsu Y.

Immunol Cell Biol. 2016 Oct;94(9):849-860. doi: 10.1038/icb.2016.49. Epub 2016 May 19.

PMID:
27192938
2.

Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation.

Fornara O, Odeberg J, Khan Z, Stragliotto G, Peredo I, Butler L, Söderberg-Nauclér C.

Immunobiology. 2013 Aug;218(8):1034-40. doi: 10.1016/j.imbio.2013.01.002. Epub 2013 Jan 16.

PMID:
23434301
3.

TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.

Tomkowicz B, Walsh E, Cotty A, Verona R, Sabins N, Kaplan F, Santulli-Marotto S, Chin CN, Mooney J, Lingham RB, Naso M, McCabe T.

PLoS One. 2015 Oct 22;10(10):e0140694. doi: 10.1371/journal.pone.0140694. eCollection 2015.

4.

Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).

Couzi L, Pitard V, Sicard X, Garrigue I, Hawchar O, Merville P, Moreau JF, Déchanet-Merville J.

Blood. 2012 Feb 9;119(6):1418-27. doi: 10.1182/blood-2011-06-363655. Epub 2011 Dec 16.

5.

Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.

Alp NJ, Allport TD, Van Zanten J, Rodgers B, Sissons JG, Borysiewicz LK.

J Virol. 1991 Sep;65(9):4812-20.

6.

Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.

Daguzan C, Moulin M, Kulyk-Barbier H, Davrinche C, Peyrottes S, Champagne E.

J Immunol. 2016 Mar 1;196(5):2219-29. doi: 10.4049/jimmunol.1501661. Epub 2016 Jan 27.

7.

Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.

Rohrlich PS, Cardinaud S, Lulè J, Montero-Julian FA, Prodhomme V, Firat H, Davignon JL, Perret E, Monseaux S, Necker A, Michelson S, Lemonnier FA, Charneau P, Davrinche C.

Hum Immunol. 2004 May;65(5):514-22.

PMID:
15172452
8.

The human cytomegalovirus glycoprotein pUL11 acts via CD45 to induce T cell IL-10 secretion.

Zischke J, Mamareli P, Pokoyski C, Gabaev I, Buyny S, Jacobs R, Falk CS, Lochner M, Sparwasser T, Schulz TF, Kay-Fedorov PC.

PLoS Pathog. 2017 Jun 19;13(6):e1006454. doi: 10.1371/journal.ppat.1006454. eCollection 2017 Jun.

9.

Ex vivo expansion of human cytomegalovirus-specific cytotoxic T cells by recombinant polyepitope: implications for HCMV immunotherapy.

Rist M, Cooper L, Elkington R, Walker S, Fazou C, Tellam J, Crough T, Khanna R.

Eur J Immunol. 2005 Mar;35(3):996-1007.

10.

Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production.

Engel P, Pérez-Carmona N, Albà MM, Robertson K, Ghazal P, Angulo A.

Immunol Cell Biol. 2011 Oct;89(7):753-66. doi: 10.1038/icb.2011.55. Epub 2011 Jun 14.

PMID:
21670740
11.

Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.

Schermann CM, Fischer G, Witt V, Kurz M, Potschger U, Fritsch G.

Cytotherapy. 2008;10(8):834-41. doi: 10.1080/14653240802474315.

PMID:
19016371
12.

The human cytomegalovirus-specific UL1 gene encodes a late-phase glycoprotein incorporated in the virion envelope.

Shikhagaie M, Mercé-Maldonado E, Isern E, Muntasell A, Albà MM, López-Botet M, Hengel H, Angulo A.

J Virol. 2012 Apr;86(8):4091-101. doi: 10.1128/JVI.06291-11. Epub 2012 Feb 15.

13.

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner.

Seggewiss R, Loré K, Greiner E, Magnusson MK, Price DA, Douek DC, Dunbar CE, Wiestner A.

Blood. 2005 Mar 15;105(6):2473-9. Epub 2004 Nov 30.

14.

CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells.

Sancho J, Ledbetter JA, Choi MS, Kanner SB, Deans JP, Terhorst C.

J Biol Chem. 1992 Apr 15;267(11):7871-9.

15.

Prior TLR5 induction in human T cells results in a transient potentiation of subsequent TCR-induced cytokine production.

Tremblay MM, Bilal MY, Houtman JC.

Mol Immunol. 2014 Feb;57(2):161-70. doi: 10.1016/j.molimm.2013.09.002. Epub 2013 Oct 12.

16.

Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection.

He F, Yao H, Xiao Z, Han J, Zou J, Liu Z.

Mol Immunol. 2014 May;59(1):30-8. doi: 10.1016/j.molimm.2013.12.004. Epub 2014 Jan 22.

PMID:
24462896
17.

NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.

Heath J, Newhook N, Comeau E, Gallant M, Fudge N, Grant M.

J Immunol Res. 2016;2016:7470124. doi: 10.1155/2016/7470124. Epub 2016 May 29.

18.

Biochemical differences in the alphabeta T cell receptor.CD3 surface complex between CD8+ and CD4+ human mature T lymphocytes.

Zapata DA, Schamel WW, Torres PS, Alarcón B, Rossi NE, Navarro MN, Toribio ML, Regueiro JR.

J Biol Chem. 2004 Jun 4;279(23):24485-92. Epub 2004 Apr 1.

19.
20.

Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.

Ulivieri C, Citro A, Ivaldi F, Mascolo D, Ghittoni R, Fanigliulo D, Manca F, Baldari CT, Li Pira G, Del Pozzo G.

Immunol Lett. 2008 Aug 15;119(1-2):62-70. doi: 10.1016/j.imlet.2008.04.004. Epub 2008 May 19.

PMID:
18538862

Supplemental Content

Support Center